Sartorius Aktiengesellschaft (SRT3) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sartorius Aktiengesellschaft (SRT3) has a cash flow conversion efficiency ratio of 0.045x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€176.40 Million ≈ $206.23 Million USD) by net assets (€3.89 Billion ≈ $4.55 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sartorius Aktiengesellschaft defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Sartorius Aktiengesellschaft - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Sartorius Aktiengesellschaft's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Sartorius Aktiengesellschaft Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sartorius Aktiengesellschaft ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PayPay Corporation American Depository Shares
NASDAQ:PAYP
|
1.056x |
|
Masimo Corporation
NASDAQ:MASI
|
0.084x |
|
Krka d. d
WAR:KRK
|
0.062x |
|
ICICI Lombard General Insurance Company Limited
NSE:ICICIGI
|
0.028x |
|
CAVA Group, Inc.
NYSE:CAVA
|
0.052x |
|
Suzhou Everbright Photonics Co. Ltd. A
SHG:688048
|
-0.001x |
|
ORIENT OVERSEAS INT.ADR/5
F:ORI
|
N/A |
|
Unigroup Guoxin Microelectronics Co Ltd
SHE:002049
|
-0.011x |
Annual Cash Flow Conversion Efficiency for Sartorius Aktiengesellschaft (2002–2025)
The table below shows the annual cash flow conversion efficiency of Sartorius Aktiengesellschaft from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Sartorius Aktiengesellschaft worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €3.87 Billion ≈ $4.52 Billion |
€656.00 Million ≈ $766.93 Million |
0.170x | -32.27% |
| 2024-12-31 | €3.90 Billion ≈ $4.56 Billion |
€976.20 Million ≈ $1.14 Billion |
0.250x | -19.10% |
| 2023-12-31 | €2.76 Billion ≈ $3.22 Billion |
€853.60 Million ≈ $997.95 Million |
0.310x | +12.11% |
| 2022-12-31 | €2.66 Billion ≈ $3.11 Billion |
€734.20 Million ≈ $858.36 Million |
0.276x | -45.14% |
| 2021-12-31 | €1.72 Billion ≈ $2.01 Billion |
€865.81 Million ≈ $1.01 Billion |
0.503x | +37.97% |
| 2020-12-31 | €1.40 Billion ≈ $1.64 Billion |
€511.52 Million ≈ $598.03 Million |
0.365x | +4.57% |
| 2019-12-31 | €1.08 Billion ≈ $1.26 Billion |
€377.19 Million ≈ $440.97 Million |
0.349x | +38.87% |
| 2018-12-31 | €973.39 Million ≈ $1.14 Billion |
€244.52 Million ≈ $285.87 Million |
0.251x | -1.89% |
| 2017-12-31 | €806.56 Million ≈ $942.95 Million |
€206.51 Million ≈ $241.43 Million |
0.256x | +10.70% |
| 2016-12-31 | €736.80 Million ≈ $861.40 Million |
€170.42 Million ≈ $199.24 Million |
0.231x | +18.96% |
| 2015-12-31 | €644.75 Million ≈ $753.78 Million |
€125.36 Million ≈ $146.56 Million |
0.194x | -25.48% |
| 2014-12-31 | €497.08 Million ≈ $581.14 Million |
€129.69 Million ≈ $151.62 Million |
0.261x | +13.76% |
| 2013-12-31 | €450.25 Million ≈ $526.39 Million |
€103.26 Million ≈ $120.72 Million |
0.229x | +74.21% |
| 2012-12-31 | €403.82 Million ≈ $472.11 Million |
€53.16 Million ≈ $62.15 Million |
0.132x | -39.03% |
| 2011-12-31 | €366.02 Million ≈ $427.92 Million |
€79.03 Million ≈ $92.40 Million |
0.216x | -26.42% |
| 2010-12-31 | €327.18 Million ≈ $382.51 Million |
€96.01 Million ≈ $112.24 Million |
0.293x | -34.66% |
| 2009-12-31 | €319.25 Million ≈ $373.23 Million |
€143.36 Million ≈ $167.61 Million |
0.449x | +182.53% |
| 2008-12-31 | €333.38 Million ≈ $389.76 Million |
€52.99 Million ≈ $61.95 Million |
0.159x | +60.24% |
| 2007-12-31 | €334.10 Million ≈ $390.60 Million |
€33.14 Million ≈ $38.75 Million |
0.099x | -67.60% |
| 2006-12-31 | €168.93 Million ≈ $197.50 Million |
€51.72 Million ≈ $60.46 Million |
0.306x | +3.56% |
| 2005-12-31 | €148.35 Million ≈ $173.44 Million |
€43.85 Million ≈ $51.27 Million |
0.296x | -20.82% |
| 2004-12-31 | €136.53 Million ≈ $159.62 Million |
€50.97 Million ≈ $59.59 Million |
0.373x | -1.18% |
| 2003-12-31 | €128.93 Million ≈ $150.73 Million |
€48.71 Million ≈ $56.95 Million |
0.378x | +50.29% |
| 2002-12-31 | €133.88 Million ≈ $156.52 Million |
€33.66 Million ≈ $39.35 Million |
0.251x | -- |
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell cult… Read more